Parkside Financial Bank & Trust’s Avadel Pharmaceuticals AVDL Stock Holding History

Parkside Financial Bank & Trust’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50	Closed	-$1.08K	–	2695
2025 Q4	$1.08K	Hold	50	–	–	﹤0.01%	2322
2025 Q3	$763	Buy	+50	New	+$651	﹤0.01%	2385
2025 Q2	–	Sell	-60	Closed	-$471	–	2753
2025 Q1	$471	Buy	+60	New	+$502	﹤0.01%	2434

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Parkside Financial Bank & Trust's AVDL Position: Q1 2026 in Review

Parkside Financial Bank & Trust sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 50 shares — an estimated $1.08K sold.

Parkside Financial Bank & Trust first reported a position in AVDL in Q1 2025 and held it in 3 quarters. The position peaked at $1.08K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Parkside Financial Bank & Trust reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Parkside Financial Bank & Trust sold 50 Avadel Pharmaceuticals shares in Q1 2026, an estimated $1.08K.
Parkside Financial Bank & Trust first reported a position in Avadel Pharmaceuticals in Q1 2025 and held it in 3 quarters.
Parkside Financial Bank & Trust's Avadel Pharmaceuticals position peaked at $1.08K in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.